檢索結果 - Scott M. Whitcup
- Showing 1 - 19 results of 19
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema 由 David S. Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K. Maturi, Albert J. Augustin, Xiaoyan Li, Harry Cui, Yehia Hashad, Scott M. Whitcup
出版 2014Artigo -
11
-
12
Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial 由 Baruch D. Kuppermann, Michaella Goldstein, Raj K. Maturi, Ayala Pollack, Michael Singer, Adnan Tufail, Dov Weinberger, Xiaoyan Li, Ching-Chi Liu, Jean Lou, Scott M. Whitcup
出版 2015Artigo -
13
Early and Long-Term Responses to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data 由 Víctor H. González, Joanna Campbell, Nancy M. Holekamp, Szilárd Kiss, Anat Loewenstein, Albert J. Augustin, Julia Ma, Allen C. Ho, Vaishali Patel, Scott M. Whitcup, Pravin U. Dugel
出版 2016Artigo -
14
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA 由 Pravin U. Dugel, Joanna Campbell, Szilárd Kiss, Anat Loewenstein, Vanessa Shih, Xiaoshu Xu, Nancy M. Holekamp, Albert J. Augustin, Allen C. Ho, Víctor H. González, Scott M. Whitcup
出版 2018Artigo -
15
Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data 由 Srinivas R. Sadda, Joanna Campbell, Pravin U. Dugel, Nancy M. Holekamp, Szilárd Kiss, Anat Loewenstein, Albert J. Augustin, Vanessa Shih, Xiaoshu Xu, Charles C. Wykoff, Scott M. Whitcup
出版 2019Artigo -
16
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial 由 Robert B. Nussenblatt, Éric Fortin, Rhett M. Schiffman, Luiz Vicente Rizzo, Janine A. Smith, Paul Van Veldhuisen, Pushpa Sran, Anita Yaffe, Carolyn K. Goldman, Thomas A. Waldmann, Scott M. Whitcup
出版 1999Artigo -
17
Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications 由 Henry F. Edelhauser, Cheryl L. Rowe-Rendleman, Michael R. Robinson, Daniel G. Dawson, Gerald J. Chader, Hans E. Grossniklaus, Kay D. Rittenhouse, Clive Wilson, David A. Weber, Baruch D. Kuppermann, Karl G. Csaky, Timothy W. Olsen, Uday B. Kompella, V. Michael Holers, Gregory S. Hageman, Brian C. Gilger, Peter A. Campochiaro, Scott M. Whitcup, Wai T. Wong
出版 2010Artigo -
18
Idiopathic Retinal Vasculitis, Aneurysms, and Neuro-retinitis 由 Tom S. Chang, G. William Aylward, Janet L. Davis, William F. Mieler, Glen L. Oliver, A. L. Maberley, Jörn‐Markus Gass, G. William Aylward, David Callanan, Tom S. Chang, Janet L. Davis, Jay S. Duker, John H. Drouilhet, David E. Eifrig, Robert B. Feldman, Jörn‐Markus Gass, Robert E. Kalina, John H. Killian, A. L. Maberley, William F. Mieler, Robert B. Nussenbatt, Glen L. Oliver, Carmen A. Puliafito, Thomas A. Rice, Howard Schatz, Scott M. Whitcup
出版 1995Artigo -
19
Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial 由 Richard A. Lewis, William C. Christie, Douglas G. Day, E. Randy Craven, Thomas R. Walters, Marina Bejanian, Susan S. Lee, Margot L. Goodkin, Jane Zhang, Scott M. Whitcup, Michael R. Robinson, Tin Aung, Allen D. Beck, William C. Christie, Michael Coote, Charles J. Crane, E. Randy Craven, Andrew Crichton, Douglas G. Day, F. Jane Durcan, William J. Flynn, Sébastien Gagné, Damien F. Goldberg, Delan Jinapriya, C. Starck Johnson, Shimon Kurtz, Richard A. Lewis, Steven L. Mansberger, Shamira Perera, Michael H. Rotberg, Robert M. Saltzmann, Howard I. Schenker, Michael Tepedino, Maria Imelda R. Yap-Veloso, Harvey S. Uy, Thomas R. Walters
出版 2016Artigo
相關主題
Medicine
Ophthalmology
Internal medicine
Surgery
Visual acuity
Diabetes mellitus
Diabetic retinopathy
Endocrinology
Immunology
Macular edema
Randomized controlled trial
Retinal
Adverse effect
Bevacizumab
Chemotherapy
Clinical endpoint
Dexamethasone
Diabetic macular edema
Implant
Inflammation
Ranibizumab
Uveitis
Immune system
Macular degeneration
Optometry
Pharmacology
Post-hoc analysis
Chemokine
Cytokine
Disease